Clinical Trials Detalhe

Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin In Patients With Fibromyalgia.

Visão Geral

Gender

ALL

Idade

N/A

Fase

PHASE3

Tipo de estudo

INTERVENTIONAL

Localização

Pfizer Investigational Site (Lisbon, Portugal)

Clinicaltrial.gov

https://classic.clinicaltrials.gov/ct2/show/NCT00333866

Sumário

This study, will compare pregabalin with placebo for the duration of 14 weeks to evaluate the efficacy and safety of pregabalin in patients with fibromyalgia.

Condições

Fibromyalgia

Elegibilidade

Inclusion Criteria: * ACR criteria for fibromyalgia * A score of more or equal to 40 mm on the Pain Visual Analog Scale (VAS) and a an average score more or equal to 4 on 4 daily pain diaries Exclusion Criteria: * Patients with other severe pain conditions * Patients with severe depression * Patients taking excluded medications